Search Results

The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.

Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

If the antibody treatment is eventually found to be viable in humans, it could increase the numbers of people who benefit from hematopoietic stem transplants, Stanford researchers said.

Just 28 when she received a new heart at Stanford Hospital in 1991, Yolanda Ishaq went on to become the first heart transplant recipient to have a child at Stanford.

Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.

Noah Hernandez, born in 2017, and James Howell, born in 1955, each benefited from a single liver to treat their life-threatening conditions.

Listing Oswaldo Jimenez for a transplant was just the beginning. His doctors needed to perform what is referred to as a “bridge-to-transplant” solution, one that would sustain his organs until transplant could be done.